Tilray
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.
| Company type | Public |
|---|---|
| Nasdaq: TLRY TSX: TLRY | |
| Industry | Cannabis, Pharmaceutical |
| Founded | 2013 |
| Founder | Brendan Kennedy |
| Headquarters | New York City , United States |
Key people | Irwin D. Simon (CEO) |
| Revenue | $627 million (2023) |
| $48.0 million (2022) | |
Number of employees | 1,600 (2023) |
| Website | Tilray.com |
In December 2020, the company announced a merger with Aphria, and will operate under the Tilray name and its ticker symbol on NASDAQ and the Toronto Stock Exchange.
Tilray also owns several breweries and is the 5th largest craft beer company in the US.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.